Sign in
4

Changes in Ownership

Nurix Therapeutics, Inc. Filed Acc 0001209191-21-039813

General Counsel sold 1,200 shares at an average $29.40 ($35,282)

  • General Counsel acquired 1,200 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Ring Christine · General Counsel

Table I: Non-derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2021-06-10 Exercise or conversion : show line 1 in the form +1,200 $1.86 $2,232 2,005 D
2021-06-10 Sale : show line 2 in the form −1,000 $29.18 $29,179 1,005 D
2021-06-10 Sale : show line 3 in the form −200 $30.52 $6,103 805 D
Open-market sales · 1,200 sh · avg $29.40 · $35,282

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2021-06-10 Exercise or conversion : show line 4 in the form Employee Stock Option (right to buy) −1,200 $1.86 2029-09-30 1,200 113,266 D
Loading xslF345X03/doc4.xml…